Article

FDA Warns Type 2 Diabetes Medications May Cause Severe Joint Pain

Health care professionals advised to discontinue drug regimen when appropriate.

Health care professionals advised to discontinue drug regimen when appropriate.

The FDA recently issued a warning for the type 2 diabetes treatments sitagliptin, saxagliptin, linagliptin, and alogliptin due to severe joint pain experienced by some users.

The joint pain can be severe and disabling, therefore caregivers should monitor these conditions. The FDA issued a new Warning and Precaution about this risk to the labels of all medications within the drug class dipeptidyl peptidase-4 (DPP-4) inhibitors.

DPP-4 inhibitors are used along with diet and exercise to lower blood sugar in adults with type 2 diabetes, a condition that can lead to blindness, nerve and kidney damage, and heart disease when left untreated.

Patients who experience joint pain from the medications indicated above should not discontinue their medication. They are advised to contact their treating physician and report the problem to the

FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

Health care professionals are advised to discontinue the medication if it seems appropriate to do so.

Related Videos
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
White pills in orange bottle with blood glucose meter on blue background
Judge gavel, pills, glucometer and stethoscope on grey background
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
The doctor tests the level of glucose in the blood, prescribes statins. Medicine diabetes concept
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Doctor checking blood sugar level with glucometer